Endovascular Today/LinkedIn
Oct 11, 2025, 18:47
Endovascular Today: SYMPHONY-PE Trial and Advances in Pulmonary Embolism Treatment
Endovascular Today shared a post on LinkedIn:
“Don’t miss an in-depth conversation on the latest evidence in pulmonary embolism treatment.
During this live webinar hosted in partnership with The PERT Consortium, Dr. Vivian Bishay, Dr. Sripal Bangalore, Dr. Sameh Sayfo, and Dr. Robert Dana Tomalty will explore results from the SYMPHONY-PE pivotal trial and discuss real-world outcomes, procedural strategies, and more.
Register here.
Sponsored by Imperative Care Vascular.”
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE